Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.55% |
| 2 | Technology | 20.49% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2776
IGC Pharma
IGC
$31.6M
| $646K | ﹤0.01% |
436,800
+138,685
| +47% | +$224K |
|
2777
Veru
VERU
$45.5M
| $646K | ﹤0.01% |
7,572
-34,938
| -82% | -$2.77M |
|
2778
Capital Bancorp
CBNK
$618M
| $645K | ﹤0.01% |
26,800
-22,500
| -46% | -$504K |
|
2779
The Bancorp
TBBK
$2.84B
| $644K | ﹤0.01% |
25,300
+8,900
| +54% | +$211K |
|
|
AMJ
2780
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $643K | ﹤0.01% |
+35,400
| New | +$643K |
|
2781
American Superconductor
AMSC
$1.54B
| $639K | ﹤0.01% |
43,808
-300,746
| -87% | -$4.17M |
|
2782
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.39B
| $637K | ﹤0.01% |
+2,700
| New | +$660K |
|
2783
X4 Pharmaceuticals
XFOR
$421M
| $637K | ﹤0.01% |
4,013
-343
| -8% | -$56.4K |
|
2784
iShares US Healthcare ETF
IYH
$3.75B
| $635K | ﹤0.01% |
+11,500
| New | +$658K |
|
2785
Integra LifeSciences
IART
$1.42B
| $634K | ﹤0.01% |
9,260
-47,800
| -84% | -$3.38M |
|
2786
Ribbon Communications
RBBN
$370M
| $634K | ﹤0.01% |
106,100
-100,800
| -49% | -$681K |
|
|
FFBW
2787
DELISTED
FFBW, Inc. Common Stock
FFBW
| $634K | ﹤0.01% |
52,626
-2,100
| -4% | -$24.3K |
|
2788
Hamilton Beach Brands
HBB
$449M
| $630K | ﹤0.01% |
40,184
-13,121
| -25% | -$235K |
|
|
MTA
2789
Metalla Royalty & Streaming
MTA
$893M
| $630K | ﹤0.01% |
+92,600
| New | +$714K |
|
2790
Taylor Devices
TAYD
$172M
| $628K | ﹤0.01% |
55,762
-1,400
| -2% | -$16.2K |
|
2791
Helix Energy Solutions
HLX
$1.54B
| $626K | ﹤0.01% |
161,230
-46,897
| -23% | -$193K |
|
|
CNTG
2792
DELISTED
Centogene N.V. Common Shares
CNTG
| $619K | ﹤0.01% |
56,200
-51,955
| -48% | -$562K |
|
2793
iShares MSCI EAFE Growth ETF
EFG
$17.3B
| $618K | ﹤0.01% |
5,800
-19,700
| -77% | -$2.17M |
|
2794
Diamondrock Hospitality Co
DRH
$2.53B
| $617K | ﹤0.01% |
65,284
-198,800
| -75% | -$1.78M |
|
|
CRON
2795
Cronos Group
CRON
$1.12B
| $615K | ﹤0.01% |
+108,645
| New | +$738K |
|
2796
Danaos Corp
DAC
$2.57B
| $614K | ﹤0.01% |
7,500
-51,600
| -87% | -$3.91M |
|
2797
Sociedad Química y Minera de Chile
SQM
$21.2B
| $612K | ﹤0.01% |
11,400
-635,900
| -98% | -$32.4M |
|
|
BNT
2798
Brookfield Wealth Solutions
BNT
$11.9B
| $610K | ﹤0.01% |
+16,500
| New | +$622K |
|
|
CLSD
2799
DELISTED
Clearside Biomedical
CLSD
| $609K | ﹤0.01% |
6,766
+2,060
| +44% | +$182K |
|
2800
iShares US Medical Devices ETF
IHI
$3.48B
| $609K | ﹤0.01% |
+9,700
| New | +$619K |
|
Similar funds
Jim Simons's Q3 2021 Portfolio in Review
As of Q3 2021, Jim Simons held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Consumer Staples.
- Jim Simons's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Jim Simons added most to Nike in Q3 2021, an estimated $453M increase.
- Jim Simons's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Jim Simons fully exited Amazon in Q3 2021, selling an estimated $897M.
- Jim Simons's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Jim Simons opened 663 new positions and closed 653 in Q3 2021.
- Jim Simons's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.